Longitudinal assessment of prognostic sex differences in lymphoma patient metabolism using PET/CT

Conclusions: In summary, LBM selectively stratifies males and rVFA selectively stratifies females with DLBCL. There are robust male-specific effects of chemotherapy on tumor metabolism and patient survival, as identified with delta SULmax. Sex differences in tumor and patient metabolism can be used to better predict outcomes and response to therapy.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Sanders, V., Teja, S., Jaswal, S., Watkins, M., Mhlanga, J., Mellnick, V., Mehta-Shah, N., Ippolito, J. Tags: Lymphoma / Leukemia Source Type: research